{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T08:46:48Z","timestamp":1787647608994,"version":"build-2736575974"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.bbi.2021.05.017","type":"journal-article","created":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T21:51:42Z","timestamp":1621461102000},"page":"106-112","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Antibodies to neuronal surface antigens in patients with a clinical diagnosis of neurodegenerative disorder"],"prefix":"10.1016","volume":"96","author":[{"given":"Maria Pia","family":"Giannoccaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Gastaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Rizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Jacobson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veria","family":"Vacchiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9539-5150","authenticated-orcid":false,"given":"Giulia","family":"Perini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1631-1439","authenticated-orcid":false,"given":"Sabina","family":"Capellari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3014-3913","authenticated-orcid":false,"given":"Diego","family":"Franciotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7312-8011","authenticated-orcid":false,"given":"Alfredo","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocco","family":"Liguori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Vincent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbi.2021.05.017_b0005","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jneuroim.2019.02.003","article-title":"A case of treatable dementia with Lewy bodies remarkably improved by immunotherapy","volume":"330","author":"Abe","year":"2019","journal-title":"J. Neuroimmunol."},{"issue":"7","key":"10.1016\/j.bbi.2021.05.017_b0010","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1001\/jamaneurol.2013.2077","article-title":"Autoantibodies in sporadic Creutzfeldt-Jakob disease","volume":"70","author":"Angus-Leppan","year":"2013","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.bbi.2021.05.017_b0015","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.bbi.2019.08.008","article-title":"Antibodies to neuronal surface proteins in Tourette Syndrome: Lack of evidence in a European paediatric cohort","volume":"81","author":"Baglioni","year":"2019","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2021.05.017_b0020","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1093\/brain\/awu142","article-title":"Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomes","volume":"137","author":"Carvajal-Gonz\u00e1lez","year":"2014","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.bbi.2021.05.017_b0025","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1001\/archneur.63.2.197","article-title":"Steroid-responsive encephalopathy associated with autoimmune thyroiditis","volume":"63","author":"Castillo","year":"2006","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.bbi.2021.05.017_b0030","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/935379","article-title":"Evaluation of incidence and clinical features of antibody-associated autoimmune encephalitis mimicking dementia","volume":"2014","author":"\u00c7oban","year":"2014","journal-title":"Behav. Neurol."},{"issue":"10","key":"10.1016\/j.bbi.2021.05.017_b0035","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/acn3.120","article-title":"High prevalence of NMDA receptor IgA\/IgM antibodies in different dementia types","volume":"1","author":"Doss","year":"2014","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"14","key":"10.1016\/j.bbi.2021.05.017_b0040","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1212\/WNL.0000000000004541","article-title":"Antibody-associated CNS syndromes without signs of inflammation in the elderly","volume":"89","author":"Escudero","year":"2017","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.bbi.2021.05.017_b0045","doi-asserted-by":"crossref","first-page":"881","DOI":"10.4065\/mcp.2010.0326","article-title":"Autoimmune dementia: clinical course and predictors of immunotherapy response","volume":"85","author":"Flanagan","year":"2010","journal-title":"Mayo Clin. Proc."},{"issue":"1\u20132","key":"10.1016\/j.bbi.2021.05.017_b0050","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jneuroim.2012.06.010","article-title":"Antibodies to N-methyl-D-aspartate glutamate receptors in Creutzfeldt-Jakob disease patients","volume":"251","author":"Fujita","year":"2012","journal-title":"J. Neuroimmunol."},{"issue":"10","key":"10.1016\/j.bbi.2021.05.017_b0055","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1007\/s00415-012-6554-y","article-title":"Voltage-gated potassium channel complex antibodies in Creutzfeldt-Jakob disease","volume":"259","author":"Fujita","year":"2012","journal-title":"J. Neurol."},{"issue":"10","key":"10.1016\/j.bbi.2021.05.017_b0060","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1001\/archneur.65.10.1341","article-title":"Voltage-gated potassium channel autoimmunity mimicking Creutzfeldt-Jakob disease","volume":"65","author":"Geschwind","year":"2008","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.bbi.2021.05.017_bib167","article-title":"Neuronal surface antibodies are common in children with narcolepsy and active movement disorders","author":"Giannoccaro","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"10.1016\/j.bbi.2021.05.017_b0065","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsw056","article-title":"Antibodies against hypocretin receptor 2 are rare in narcolepsy","volume":"40","author":"Giannoccaro","year":"2017","journal-title":"Sleep"},{"issue":"3","key":"10.1016\/j.bbi.2021.05.017_b0070","doi-asserted-by":"crossref","first-page":"761","DOI":"10.3233\/JAD-170882","article-title":"Antibodies to multiple receptors are associated with neuropsychiatric symptoms and mortality in Alzheimer's disease: a longitudinal study","volume":"64","author":"Giil","year":"2018","journal-title":"J. Alzheimers Dis."},{"issue":"1","key":"10.1016\/j.bbi.2021.05.017_b0075","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1001\/jamaneurol.2013.4857","article-title":"Determination of neuronal antibodies in suspected and definite Creutzfeldt-Jakob disease","volume":"71","author":"Grau-Rivera","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.bbi.2021.05.017_b0080","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol."},{"issue":"16","key":"10.1016\/j.bbi.2021.05.017_b0085","doi-asserted-by":"crossref","first-page":"e1386","DOI":"10.1212\/WNL.0000000000005329","article-title":"Clinical and pathogenic significance of IgG, IgA, and IgM antibodies against the NMDA receptor","volume":"90","author":"Hara","year":"2018","journal-title":"Neurology."},{"issue":"9","key":"10.1016\/j.bbi.2021.05.017_b0090","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1093\/brain\/awq213","article-title":"Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan\u2019s syndrome and acquired neuromyotonia","volume":"133","author":"Irani","year":"2010","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.bbi.2021.05.017_b0095","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/ana.20693","article-title":"Rapid eye movement sleep behavior disorder and potassium channel antibody-associated limbic encephalitis","volume":"59","author":"Iranzo","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbi.2021.05.017_b0100","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jns.2016.01.006","article-title":"Autoimmune atypical parkinsonism \u2013 A group of treatable parkinsonism","volume":"362","author":"Kannoth","year":"2016","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.bbi.2021.05.017_b0105","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.parkreldis.2015.08.014","article-title":"Immunomodulated parkinsonism as a presenting symptom of LGI1 antibody encephalitis","volume":"21","author":"Kurtis","year":"2015","journal-title":"Parkinsonism Relat. Disord."},{"issue":"9","key":"10.1016\/j.bbi.2021.05.017_b0110","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1007\/s00415-012-6489-3","article-title":"NMDA receptor autoantibodies in sporadic Creutzfeldt-Jakob disease","volume":"259","author":"Mackay","year":"2012","journal-title":"J. Neurol."},{"issue":"2","key":"10.1016\/j.bbi.2021.05.017_b0115","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1001\/jamaneurol.2014.3602","article-title":"Antibodies to aquaporin 4, myelin-oligodendrocyte glycoprotein, and the glycine receptor \u03b11 subunit in patients with isolated optic neuritis","volume":"72","author":"Martinez-Hernandez","year":"2015","journal-title":"JAMA Neurol."},{"issue":"10","key":"10.1016\/j.bbi.2021.05.017_b0125","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1001\/archneur.64.10.1528","article-title":"Potassium channel antibody associated encephalopathy presenting with a fronto- temporal dementia like syndrome","volume":"64","author":"McKeon","year":"2007","journal-title":"Arch. Neurol."},{"issue":"5","key":"10.1016\/j.bbi.2021.05.017_b0130","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000592","article-title":"Novel clinical features of glycine receptor antibody syndrome: a series of 17 cases","volume":"6","author":"Piquet","year":"2019","journal-title":"Neurol Neuroimmunol. Neuroinflamm."},{"issue":"9","key":"10.1016\/j.bbi.2021.05.017_b0135","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.4065\/81.9.1207","article-title":"Glutamic acid decarboxylase autoimmunity with brainstem, extrapyramidal, and spinal cord dysfunction","volume":"81","author":"Pittock","year":"2006","journal-title":"Mayo Clin. Proc."},{"issue":"6","key":"10.1016\/j.bbi.2021.05.017_b0140","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1002\/ana.23689","article-title":"N-methyl-D-aspartate receptor antibodies in herpes simplex encephalitis","volume":"72","author":"Pr\u00fcss","year":"2012","journal-title":"Ann. Neurol."},{"issue":"22","key":"10.1016\/j.bbi.2021.05.017_b9000","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1212\/WNL.0b013e318258300d","article-title":"IgA NMDA receptor antibodies are markers of synaptic immunity in slow cognitive impairment","volume":"78","author":"Pr\u00fcss","year":"2012","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.bbi.2021.05.017_b0145","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1136\/jnnp-2014-308695","article-title":"Neuronal antibodies in patients with suspected or confirmed sporadic Creutzfeldt-Jakob disease","volume":"86","author":"Rossi","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"6","key":"10.1016\/j.bbi.2021.05.017_b0150","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S1474-4422(14)70051-1","article-title":"A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study","volume":"13","author":"Sabater","year":"2014","journal-title":"Lancet Neurol."},{"issue":"10","key":"10.1016\/j.bbi.2021.05.017_b0155","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1111\/ene.13721","article-title":"Antiglycine receptor antibody related disease: a case series and literature review","volume":"25","author":"Swayne","year":"2018","journal-title":"Eur. J. Neurol."},{"issue":"20","key":"10.1016\/j.bbi.2021.05.017_b0165","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1212\/WNL.0000000000000991","article-title":"DPPX potassium channel antibody: frequency, clinical accompaniments, and outcomes in 20 patients","volume":"83","author":"Tobin","year":"2014","journal-title":"Neurology"}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159121001987?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159121001987?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T08:09:59Z","timestamp":1760170199000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159121001987"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":33,"alternative-id":["S0889159121001987"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2021.05.017","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibodies to neuronal surface antigens in patients with a clinical diagnosis of neurodegenerative disorder","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2021.05.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}